Target was Hit on BioCryst Pharma $BCRX at $11 for a 21.5 % Gain (Long Term Portfolio).


Please login if a current member. If not a Green Line member, you can join below.



The post Target was Hit on BioCryst Pharma $BCRX at $11 for a 21.5 % Gain (Long Term Portfolio). appeared first on Above The Green Line.

We will be happy to hear your thoughts

Leave a reply

Som2ny Network
Logo
Compare items
  • Total (0)
Compare
0
Shopping cart